Suppr超能文献

高分级肢体骨肉瘤转移后的生存率:126例患者预后因素的回顾性分析

Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.

作者信息

Kim Wanlim, Han Ilkyu, Lee Jong S, Cho Hwan S, Park Jong W, Kim Han-Soo

机构信息

Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.

Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea.

出版信息

J Surg Oncol. 2018 May;117(6):1223-1231. doi: 10.1002/jso.24963. Epub 2018 Feb 6.

Abstract

BACKGROUND AND OBJECTIVES

Prognostic factors predictive of postmetastasis survival (PMS) in metastatic osteosarcoma are poorly understood. Our aims were to evaluate PMS in patients with high-grade osteosarcoma in extremities, and to identify prognostic factors related to PMS.

METHODS

A retrospective review of data for 126 patients with metastatic osteosarcoma was conducted. The study population consisted of 70 men and 56 women, with a mean age of 21 years (range: 4-75 years). The mean postmetastasis follow-up period was 37 months (range: 1-245 months).

RESULTS

The 5-year PMS rate was 31% and median PMS duration was 22 months. In the multivariate analyses, no metastasectomy (P < 0.001), local recurrence prior to metastasis (P = 0.016), extrapulmonary metastasis (P = 0.006), and poor histologic response to preoperative chemotherapy (P = 0.047) were significant poor prognostic factors. The 5-year PMS without any negative prognostic factor was 60.2%; with one factor, 31.6%; and with more than two factors, 3.6%.

CONCLUSIONS

PMS in osteosarcoma patients was influenced by primary tumor-related factors such as histologic response to chemotherapy, as well as metastasis-related factors such as complete metastasectomy and metastasis site. A certain group of patients without such poor prognostic factors could be cured even after the development of metastasis.

摘要

背景与目的

转移性骨肉瘤转移后生存(PMS)的预测预后因素尚不清楚。我们的目的是评估四肢高级别骨肉瘤患者的PMS,并确定与PMS相关的预后因素。

方法

对126例转移性骨肉瘤患者的数据进行回顾性分析。研究人群包括70名男性和56名女性,平均年龄21岁(范围:4 - 75岁)。转移后的平均随访时间为37个月(范围:1 - 245个月)。

结果

5年PMS率为31%,中位PMS持续时间为22个月。在多变量分析中,未进行转移灶切除术(P < 0.001)、转移前局部复发(P = 0.016)、肺外转移(P = 0.006)以及对术前化疗的组织学反应较差(P = 0.047)是显著的不良预后因素。无任何不良预后因素的5年PMS为60.2%;有一个因素的为31.6%;有两个以上因素的为3.6%。

结论

骨肉瘤患者的PMS受原发性肿瘤相关因素(如对化疗的组织学反应)以及转移相关因素(如完整的转移灶切除术和转移部位)的影响。即使在发生转移后,某些没有这些不良预后因素的患者组也可能治愈。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验